-
公开(公告)号:US08735590B2
公开(公告)日:2014-05-27
申请号:US13354426
申请日:2012-01-20
IPC分类号: C07D211/26 , C07D309/12
CPC分类号: C07D295/13 , C07D309/12
摘要: The present invention provides bicyclo-heptan-2-amines that selectively bind to the sigma-2 receptor and are useful in the treatment of diseases related to the sigma-2 receptor, for example, cancer and neurological disorders.
摘要翻译: 本发明提供了选择性结合σ-2受体并可用于治疗与σ-2受体有关的疾病,例如癌症和神经障碍的双环庚烷-2-胺。
-
公开(公告)号:US20120190710A1
公开(公告)日:2012-07-26
申请号:US13354426
申请日:2012-01-20
IPC分类号: A61K31/4453 , C07D309/12 , A61P25/16 , A61P35/00 , A61P25/00 , C07D211/26 , A61K31/351
CPC分类号: C07D295/13 , C07D309/12
摘要: The present invention provides bicyclo-heptan-2-amines that selectively bind to the sigma-2 receptor and are useful in the treatment of diseases related to the sigma-2 receptor, for example, cancer and neurological disorders.
摘要翻译: 本发明提供了选择性结合σ-2受体并可用于治疗与σ-2受体有关的疾病,例如癌症和神经障碍的双环庚烷-2-胺。
-